250 related articles for article (PubMed ID: 30304987)
1. An integrated framework for identification of effective and synergistic anti-cancer drug combinations.
Sharma A; Rani R
J Bioinform Comput Biol; 2018 Oct; 16(5):1850017. PubMed ID: 30304987
[TBL] [Abstract][Full Text] [Related]
2. A Computational Approach for Identifying Synergistic Drug Combinations.
Gayvert KM; Aly O; Platt J; Bosenberg MW; Stern DF; Elemento O
PLoS Comput Biol; 2017 Jan; 13(1):e1005308. PubMed ID: 28085880
[TBL] [Abstract][Full Text] [Related]
3. Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment.
Friedman AA; Amzallag A; Pruteanu-Malinici I; Baniya S; Cooper ZA; Piris A; Hargreaves L; Igras V; Frederick DT; Lawrence DP; Haber DA; Flaherty KT; Wargo JA; Ramaswamy S; Benes CH; Fisher DE
PLoS One; 2015; 10(10):e0140310. PubMed ID: 26461489
[TBL] [Abstract][Full Text] [Related]
4. SNSynergy: Similarity network-based machine learning framework for synergy prediction towards new cell lines and new anticancer drug combinations.
Huangfu X; Zhang C; Li H; Li S; Li Y
Comput Biol Chem; 2024 Jun; 110():108054. PubMed ID: 38522389
[TBL] [Abstract][Full Text] [Related]
5. In-silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-omics Data.
Celebi R; Bear Don't Walk O; Movva R; Alpsoy S; Dumontier M
Sci Rep; 2019 Jun; 9(1):8949. PubMed ID: 31222109
[TBL] [Abstract][Full Text] [Related]
6. In silico drug combination discovery for personalized cancer therapy.
Jeon M; Kim S; Park S; Lee H; Kang J
BMC Syst Biol; 2018 Mar; 12(Suppl 2):16. PubMed ID: 29560824
[TBL] [Abstract][Full Text] [Related]
7. Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes.
Regan-Fendt KE; Xu J; DiVincenzo M; Duggan MC; Shakya R; Na R; Carson WE; Payne PRO; Li F
NPJ Syst Biol Appl; 2019; 5():6. PubMed ID: 30820351
[TBL] [Abstract][Full Text] [Related]
8. H-RACS: a handy tool to rank anti-cancer synergistic drugs.
Yan X; Yang Y; Chen Z; Yin Z; Deng Z; Qiu T; Tang K; Cao Z
Aging (Albany NY); 2020 Nov; 12(21):21504-21517. PubMed ID: 33173014
[TBL] [Abstract][Full Text] [Related]
9. Network Propagation Predicts Drug Synergy in Cancers.
Li H; Li T; Quang D; Guan Y
Cancer Res; 2018 Sep; 78(18):5446-5457. PubMed ID: 30054332
[TBL] [Abstract][Full Text] [Related]
10. Unbiased High-Throughput Drug Combination Pilot Screening Identifies Synergistic Drug Combinations Effective against Patient-Derived and Drug-Resistant Melanoma Cell Lines.
Close DA; Kirkwood JM; Fecek RJ; Storkus WJ; Johnston PA
SLAS Discov; 2021 Jun; 26(5):712-729. PubMed ID: 33208016
[TBL] [Abstract][Full Text] [Related]
11. Selective Targeting of CTNBB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs.
Uitdehaag JC; de Roos JA; van Doornmalen AM; Prinsen MB; Spijkers-Hagelstein JA; de Vetter JR; de Man J; Buijsman RC; Zaman GJ
PLoS One; 2015; 10(5):e0125021. PubMed ID: 26018524
[TBL] [Abstract][Full Text] [Related]
12. A novel approach to predicting the synergy of anti-cancer drug combinations using document-based feature extraction.
Shim Y; Lee M; Kim PJ; Kim HG
BMC Bioinformatics; 2022 May; 23(1):163. PubMed ID: 35513784
[TBL] [Abstract][Full Text] [Related]
13. Stratification and prediction of drug synergy based on target functional similarity.
Yang M; Jaaks P; Dry J; Garnett M; Menden MP; Saez-Rodriguez J
NPJ Syst Biol Appl; 2020 Jun; 6(1):16. PubMed ID: 32487991
[TBL] [Abstract][Full Text] [Related]
14. A Combinatorial Strategy for Targeting
Ghosh C; Kumar S; Kushchayeva Y; Gaskins K; Boufraqech M; Wei D; Gara SK; Zhang L; Zhang YQ; Shen M; Mukherjee S; Kebebew E
Clin Cancer Res; 2020 Apr; 26(8):2022-2036. PubMed ID: 31937621
[TBL] [Abstract][Full Text] [Related]
15. Predicting drug synergy for precision medicine using network biology and machine learning.
Cuvitoglu A; Zhou JX; Huang S; Isik Z
J Bioinform Comput Biol; 2019 Apr; 17(2):1950012. PubMed ID: 31057072
[TBL] [Abstract][Full Text] [Related]
16. Genotype-selective combination therapies for melanoma identified by high-throughput drug screening.
Held MA; Langdon CG; Platt JT; Graham-Steed T; Liu Z; Chakraborty A; Bacchiocchi A; Koo A; Haskins JW; Bosenberg MW; Stern DF
Cancer Discov; 2013 Jan; 3(1):52-67. PubMed ID: 23239741
[TBL] [Abstract][Full Text] [Related]
17. Methods for High-throughput Drug Combination Screening and Synergy Scoring.
He L; Kulesskiy E; Saarela J; Turunen L; Wennerberg K; Aittokallio T; Tang J
Methods Mol Biol; 2018; 1711():351-398. PubMed ID: 29344898
[TBL] [Abstract][Full Text] [Related]
18. DrugCombDB: a comprehensive database of drug combinations toward the discovery of combinatorial therapy.
Liu H; Zhang W; Zou B; Wang J; Deng Y; Deng L
Nucleic Acids Res; 2020 Jan; 48(D1):D871-D881. PubMed ID: 31665429
[TBL] [Abstract][Full Text] [Related]
19. Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs.
Abd El-Hafeez T; Shams MY; Elshaier YAMM; Farghaly HM; Hassanien AE
Sci Rep; 2024 Jan; 14(1):2428. PubMed ID: 38287066
[TBL] [Abstract][Full Text] [Related]
20. Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells.
Margue C; Philippidou D; Kozar I; Cesi G; Felten P; Kulms D; Letellier E; Haan C; Kreis S
J Exp Clin Cancer Res; 2019 Feb; 38(1):56. PubMed ID: 30728057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]